Skip to main content
Clinical Trials/NCT02763150
NCT02763150
Completed
Not Applicable

Gestational Diabetes Prevention Program

California Polytechnic State University-San Luis Obispo2 sites in 1 country199 target enrollmentDecember 15, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gestational Diabetes Mellitus
Sponsor
California Polytechnic State University-San Luis Obispo
Enrollment
199
Locations
2
Primary Endpoint
Incidence of Gestational Diabetes Mellitus
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The overall purpose of this study is to determine the efficacy of a pre-pregnancy lifestyle intervention to reduce the recurrence of gestational diabetes mellitus in multiethnic women with overweight or obesity.

Registry
clinicaltrials.gov
Start Date
December 15, 2017
End Date
July 29, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
California Polytechnic State University-San Luis Obispo
Responsible Party
Principal Investigator
Principal Investigator

Suzanne Phelan

Professor

California Polytechnic State University-San Luis Obispo

Eligibility Criteria

Inclusion Criteria

  • Prior diagnosis of gestational diabetes.
  • BMI \> 25 kg/m2
  • Planning to have a baby in the next 1-3 years
  • English or Spanish speaking

Exclusion Criteria

  • Age less than 18 years
  • Women with Type 2 or Type 1 diabetes
  • Current pregnancy
  • Relocating in the next 2 years
  • Medications that affect weight/diabetes
  • Serious current physical disease
  • History of eating disorders
  • History of bariatric surgery
  • Current problems with drug abuse
  • Current treatment of a serious psychological disorder

Outcomes

Primary Outcomes

Incidence of Gestational Diabetes Mellitus

Time Frame: 26 weeks gestation

Secondary Outcomes

  • Changes in maternal levels of fasting glucose(study entry, 16 weeks, 26 weeks gestation)
  • Changes in maternal levels of fasting insulin(study entry, 16 weeks, 26 weeks gestation)
  • Incidence of cesarean delivery(Delivery)
  • Daily caloric intake(study entry, 16 weeks, 26 weeks gestation)
  • Changes in maternal levels of systolic and diastolic blood pressure(study entry, 16 weeks, 26 weeks gestation)
  • Changes in maternal levels of C-reactive protein(study entry, 16 weeks, 26 weeks gestation)
  • Incidence of preeclampsia(Delivery)
  • Minutes per week of moderate physical activity(study entry, 16 weeks, 26 weeks gestation)
  • Weight changes(study entry, 16 weeks, 26 weeks gestation)

Study Sites (2)

Loading locations...

Similar Trials